Description

JV-1-36 is a growth hormone-releasing hormone (GHRH) antagonist. JV-1-36 inhibits the production of reactive oxygen species in A549 lung cancer cells. JV-1-36 can be used to study the effect of GHRH antagonists in vitro [1].—Cancer-programmed cell death–C172H284ClN53O41—-[1]Kubra KT, et al. Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells. Endocrines. 2022 Dec;3(4):813-820.–221377-79-3–3785.88—-N=C(NCCC[C@@H](NC([C@@H](NC(CC1=CC=CC=C1)=O)CC2=CC=C(C=C2)O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](C(N[C@H](C(N)=O)CCCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCC)=O)[C@H](CC)C)=O)CC(O)=O)=O)CCC(N)=O)=O)CC(C)C)=O)CC(C)C)=O)CCCCN)=O)CCCNC(N)=N)=O)C)=O)CO)=O)CC(C)C)=O)CCC(N)=O)=O)CC)=O)CC(C)C)=O)C(C)C)=O)CCCCN)=O)CCCNC(N)=N)=O)CC3=CC=C(OC)C=C3)=O)CCCCNC(N)=N)=O)CC(N)=O)=O)[C@@H](C)O)=O)CC4=CC=C(Cl)C=C4)=O)[C@H](CC)C)=O)C)=O)CC(O)=O)=O)N–Cancer–10 mM in DMSO–Others—-Others–Peptides